LAYTON, Utah, June 1 -- Computerized Thermal Imaging, Inc. (CTI) has retained Battelle Medical Products to assist with the formal FDA approval process for CTI's Thermal Breast Imaging System. We decided to retain the services of Battelle Medical Products because there is nothing more critical for this company than to successfully complete the submission of clinical data to the FDA as quickly and expeditiously as possible, said David A. Packer, president of CTI. Battelle is one of the most respected technology companies in the world, having delivered technology-based value to industry and government for nearly 70 years. We believe that by having them as part of our team, we will be able to avoid many of the pitfalls that might cause unanticipated delays in the approval process.